skip navigation, go to content
Neuroprotection Exploratory Trials in Parkinson's Disease: NET-PD National Institute of Neurological Disorders and Stroke logo
National Institutes of Health
[What is the NET-PD Study?]
[Who is sponsoring NET-PD?]
[Enrolling now: FS-Zone]
[What other drugs are being studied?]
[Study news publications]
[Privacy and confidentiality]
[En Espaņol]
[For more information, call toll free 1-800-352-9424 email or visit] Learn more about NET-PD clinical trials for Parkinson's Disease
[Parkinson's Study]

The National Institute of Neurological Disorders and Stroke, part of the National Institutes of Health, is looking for individuals with Parkinson's disease to participate in NIH Exploratory Trials in Parkinson's Disease (NET-PD). NET-PD is a series of clinical research studies conducted at approximately 50 centers across the country and in Canada in an effort to find drugs to slow the progression of Parkinson's.

Current therapies are able to effectively treat the symptoms of PD. However, over time, these therapies may be less effective and the disease process continues. Therefore it is important to identify agents that are able to slow disease progression.

The NET-PD FS-ZONE Phase II trial has reached its conclusion. Patients are no longer being recruited or enrolled in this study.
[Participating in a clinical study allows you to play an active role in developing future treatments for Parkinson's disease.]

NET-PD Home | What is the NET-PD Study? | Who is sponsoring NET-PD? | Enrolling now: FS-Zone
What other drugs are being studied? | Study publications | Privacy and confidentiality | En Espaņol
NINDS Home | Download Adobe Reader

U.S. Department of Health and Human Services logo     National Institutes of Health logo logo

NIH...Turning Discovery Into Health®